These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32398281)

  • 81. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review.
    Kilian A; Chock YP; Huang IJ; Graef ER; Upton LA; Khilnani A; Krupnikova SDS; Almaghlouth I; Cappelli LC; Fernandez-Ruiz R; Frankel BA; Frankovich J; Harrison C; Kumar B; Monga K; Vega JAR; Singh N; Sparks JA; Sullo E; Young KJ; Duarte-Garcia A; Putman M; Johnson S; Grainger R; Wallace ZS; Liew JW; Jayatilleke A
    Semin Arthritis Rheum; 2020 Oct; 50(5):1191-1201. PubMed ID: 32931985
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association of patient copayment and medication adherence in systemic lupus erythematosus.
    Lomanto Silva R; Swabe GM; Sattui SE; Magnani JW
    Lupus Sci Med; 2023 Oct; 10(2):. PubMed ID: 37852670
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
    Mendel A; Bernatsky S; Askanase A; Bae SC; Clarke AE; Costedoat-Chalumeau N; Gladman DD; Gordon C; Hanly J; Jacobsen S; Kalunian K; Mak A; Mosca M; Pons-Estel BA; Ruiz-Irastorza G; Urowitz M; Vinet É
    Ann Rheum Dis; 2021 Feb; 80(2):1-2. PubMed ID: 32586918
    [No Abstract]   [Full Text] [Related]  

  • 84. Hydroxychloroquine and immunosuppressant adherence patterns and their association with subsequent hospitalization rates among children with systemic lupus erythematosus.
    Chang JC; Costenbader KH
    Semin Arthritis Rheum; 2022 Oct; 56():152042. PubMed ID: 35738041
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Acute respiratory distress syndrome and COVID-19 in a child with systemic lupus erythematosus.
    Sukhdeo S; Negroponte E; Rajasekhar H; Gaur S; Horton DB; Malhotra A; Moorthy LN
    Lupus; 2021 Apr; 30(5):836-839. PubMed ID: 33509065
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hydroxychloroquine shortages during the COVID-19 pandemic.
    Mendel A; Bernatsky S; Thorne JC; Lacaille D; Johnson SR; Vinet É
    Ann Rheum Dis; 2021 Mar; 80(3):e31. PubMed ID: 32434820
    [No Abstract]   [Full Text] [Related]  

  • 87. Infections and systemic lupus erythematosus.
    Skare TL; Dagostini JS; Zanardi PI; Nisihara RM
    Einstein (Sao Paulo); 2016; 14(1):47-51. PubMed ID: 27074234
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year.
    Ramirez GA; Argolini LM; Bellocchi C; Moroni L; Della-Torre E; Farina N; Caporali RF; Beretta L; Gerosa M; Bozzolo EP; Dagna L;
    Clin Immunol; 2021 Oct; 231():108845. PubMed ID: 34478882
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments.
    Gendebien Z; von Frenckell C; Ribbens C; André B; Thys M; Gangolf M; Seidel L; Malaise MG; Malaise O
    Ann Rheum Dis; 2021 Jun; 80(6):e94. PubMed ID: 32586921
    [No Abstract]   [Full Text] [Related]  

  • 90. Meningoencephalitis associated with COVID-19: a systematic review.
    Mondal R; Ganguly U; Deb S; Shome G; Pramanik S; Bandyopadhyay D; Lahiri D
    J Neurovirol; 2021 Feb; 27(1):12-25. PubMed ID: 33367960
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Heart transplant recipient patient with COVID-19 treated with tocilizumab.
    Mattioli M; Fustini E; Gennarini S
    Transpl Infect Dis; 2020 Dec; 22(6):e13380. PubMed ID: 32573990
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Role of Immunosuppression in the Development of COVID-19 in Systemic Lupus Erythematosus Patients: A Brief Report.
    Damirchi M; Aghaie M; Sedighi S; Tavassoli S; Roshandel G; Hassani M; Abdolahi N
    Iran J Med Sci; 2023 Jan; 48(1):91-97. PubMed ID: 36688192
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Shedding light on therapeutics in alopecia and their relevance to COVID-19.
    Fagan N; Meah N; York K; Bokhari L; Fletcher G; Chen G; Tobin DJ; Messenger A; Irvine AD; Sinclair R; Wall D
    Clin Dermatol; 2021; 39(1):76-83. PubMed ID: 33972056
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Response to 'Impact of COVID-19 pandemic on hospitalisation of patients with systemic lupus erythematosus (SLE): report from a tertiary hospital during the peak of the pandemic' by Chuah
    Mathian A; Amoura Z
    Ann Rheum Dis; 2022 Aug; 81(8):e145. PubMed ID: 32883652
    [No Abstract]   [Full Text] [Related]  

  • 95. Concerns and needs of patients with systemic lupus erythematosus regarding hydroxychloroquine supplies during the COVID-19 pandemic: results from a patient-centred survey.
    Plüß M; Chehab G; Korsten P
    Ann Rheum Dis; 2021 Apr; 80(4):e52. PubMed ID: 32616604
    [No Abstract]   [Full Text] [Related]  

  • 96. Response to: 'COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases' by Lopez-Medina
    Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
    Ann Rheum Dis; 2021 Apr; 80(4):e51. PubMed ID: 32503850
    [No Abstract]   [Full Text] [Related]  

  • 97. COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine.
    Teh CL; Cheong YK; Wan Musa WR; Wan Mohd Akbar SA; Mat Husin N; Gun SC
    Ann Rheum Dis; 2021 May; 80(5):e69. PubMed ID: 32737111
    [No Abstract]   [Full Text] [Related]  

  • 98. Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh
    Mathian A; Amoura Z
    Ann Rheum Dis; 2021 May; 80(5):e70. PubMed ID: 32737109
    [No Abstract]   [Full Text] [Related]  

  • 99. SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study.
    Mageau A; Aldebert G; Van Gysel D; Papo T; Timsit JF; Sacre K
    Ann Rheum Dis; 2021 Aug; 80(8):1101-1102. PubMed ID: 33727216
    [No Abstract]   [Full Text] [Related]  

  • 100. Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak.
    Holubar J; Le Quintrec M; Letaief H; Faillie JL; Pers YM; Jorgensen C
    Ann Rheum Dis; 2021 Apr; 80(4):e56. PubMed ID: 32513650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.